Tuesday, April 9

Welcome
Rick A. Greco, DO, MACOI & Mia A. Taormina, DO, FACOI

8:00-9:00 AM  Diabetes and CKM Syndrome: Treating More than the Triad 
John R. Sutton, DO, MACOI
In this session you will learn:

• The stages of CKM syndrome
• The AHA Life's Essential 8
• The CKM syndrome treatment recommendations

9:05-9:50 AM  Transitions Between Inpatient and Outpatient Management of Diabetic Patients
Quang T. Nguyen, DO
In this session you'll learn:

• The key challenges and factors influencing the transition from inpatient to outpatient management in chronic pain patients
• Best practices for developing personalized care plans to facilitate seamless transitions and improve patient outcomes
• Challenges associated with transitions and identify solutions to overcome barriers for more effective chronic pain management

9:55-10:40 AM  Understanding Obesity Management: GLP-1 Agents and  Weight Loss
Jeffrey S. Freeman, DO, FACOI
In this session you will discuss:

• The epidemic of obesity
• The physiologic basis of GLP and GLP-GIP
• Clinical trials and clinical applications of GLP and GLP-GIP use for treatment of obesity

10:45-11:30 AM  To Transfuse or Not to Transfuse: A Review of Blood and Blood Product Guidelines
Minh-Ha Tran, DO
In this session you'll learn:

• The origins of commonly held transfusion practices
• The key principles underlying transfusion therapy
• Current recommendations for red cell and platelet transfusion thresholds

11:35 AM - 12:20 PM  Presentation of Acute Adverse Drug Reactions to Common Chemotherapeutic Drugs
Joseph W. McCollom, DO, FACOI
In this session you will learn:

• The grades of chemotherapy related nausea and anemia and approaches to prevention and treatment
• Quality of life impacting chemotherapy induced peripheral neuropathy and fatigue as well as strategies to mitigate it
• Unique toxicities of immunotherapy agents, steroid responsiveness as well as strategies in endocrinopathies and steroid refractory disease

12:25-1:10 PM  Management of ESRD Patient Who Desires In-Home Dialysis
Mark D. Baldwin, DO, FACOI
In this session you'll learn:

• The basic terms of dry weight, access, dialysate, return, and ultrafiltrate and principles of dialysis and fluid removal
• The basic structure and types of home dialysis, the benefits, and appropriates patients
• The care of dialysis access and commonly associated conditions and treatments

1:15-2:00 PM  Acute Kidney Injury: An Update
Anis Rauf, DO

2:05 - 2:50 PM  Diverticulitis Disease
Herbert L. Pasternack, DO, FACOI

2:55-3:25 PM  Endoscopic Advances in GI
Tolga Erim, DO
In this session you'll learn:

• Endoscopic role of treatment of pancreatic fluid collections
• Novel lumen apposing metal stent uses in endoscopy
• Different endoscopic modalities for treating bile duct and pancreatic dust strictures

3:30-4:20 PM  New Therapies in GI 
Robert Aran, DO
In this session you'll learn to:

• Define ALF and etiologies
• Differentiate acue on chronic liver failure from acute liver failure
• Develop a therapy plan for ALF and ACLF

Wednesday, April 10

8:00 - 8:45 AM  Goal Directed Medical Therapy for the Management of Congestive Heart Failure
Arash Karnama, DO, FACOI
In this session you'll learn:

• The pathophysiology of congestive heart failure
• Non-pharmacologic management options for congestive heart failure
• Guideline Directed Medical Therapy for heart failure with reduced and preserved ejection fraction

8:50 - 9:35 AM  Review of Non-Invasive Diagnosis in Coronary Artery Disease
Vik Gongidi, DO, FACOI

9:40 - 10:30 AM  Hospitalist Role in Length of Stay
Beth J. Makowski Shell, DO, FACOI
In this session you'll learn:

• Trends and drivers of increasing length of stay
• To identify clinical vs. operational opportunities in length of stay improvement
• To engage hospitalist teams for length of stay improvement

10:35-11:30 AM  Work-up of the Hospitalized Fever of Unknown Origin Patient when Infectious Disease Work-up is Unrevealing 
Christian M. Chiaveta, DO, FACOI
In this session you will learn:

• What a fever of unknown origin is and how the definition has changed over the years
• The epidemiology, classifications, and diagnostic workup of the infectious and non-infectious fever of unknown origin
• Causes and cases of non-infectious fever of unknown origin, including treatment

11:35-12:20 PM  Medical Management After Hip Fragility Fracture
Mikhail Signalov, DO, FACOI
In this session you will:

• Review the current clinical definition and diagnostic criteria for osteoporosis
• Review FRAX® as one of the primary ways to calculate potential fragility fracture risk
• Review the current pharmacological treatment options for patients with osteoporosis
• Learn to recognize clinical aspects of fragility hip fractures as initial presentations of osteoporosis in many patients and the importance of postoperative medical management for secondary fracture prevention

12:25-1:05 PM  Contact and Airborne and Droplet, Oh My!  A Review of Hospital Isolation Guidelines
Mia A. Taormina, DO, FACOI
In this session you'll learn:

• The basic types of hospital isolation
• Disease specific isolation policies and procedures
• About the duration of isolation and criteria to discontinue

1:10-1:40 PM  When Your IV Drug Abuser Needs Long-Course Antibiotics and Aftercare  
Mia A. Taormina, DO, FACOI
In this session you will:

• Review the data regarding PICC line placement in higher risk individuals
• Review and discuss infections that typically require longer course intravenous antibiotics and the complexities of administering to individuals with IV drug abuse histories
• Discuss the data behind the use of long-course oral antibiotics as potential alternative treatment strategies for these infections

1:45-2:30 PM  Leveraging Rapid Diagnostic Testing to Expediate Diagnosis and Treatment of Hospitalized Patients
MarkAlain Dery, DO, MPH, FACOI
In this session you'll learn:

• To compare and contrast the 3 main rapid diagnostic tests
• To identify the application of rapid diagnostic tests in clinical scenarios
• To recognize that in the field of infectious diseases, biomarkers are biological surrogates of infection or predictors of certain outcomes

2:35-3:15 PM  Gender-Affirming Therapy: No Longer Specialized Care  
Danit Ariel, MD, MS
In this session you will learn:

• Key concepts and terms pertaining to transgender and gender diverse identities
• The principles of creating respectful and inclusive clinical environment
• The principles of gender-affirming hormone therapy
• Key medical conditions and how they may impact transgender women and men

3:20-4:05 PM  Inpatient Management of the Medically or Surgically Affirmed Transgender Patient  
Ole-Petter R. Hamnvik, MB BCh BAO, MMSc, MRCPI
In this session you'll learn:

• Key concepts and terms pertaining to transgender and gender diverse identities
• The principles of gender-affirming hormone therapy
• Approaches to management of gender-affirming hormones in patients admitted to the hospital

Thursday, April 11

8:00-9:00 AM  Heart to Heart with the Grim Reaper: Identifying and Referring Patients with Advanced Heart Failure 
Steven Antoine, MD
In this session you will learn:

• The pathophysiology, morbidity, and mortality associated with end stage heart failure
• How to identify and when to refer your patients with heart failure to an advanced heart failure specialist 
• The different therapies available for patients with advanced heart failure

9:05-9:50 AM  Inpatient Management of the HIV Patient  
Andrea Sciberras, DO, FACOI
In this session you'll:

• Become knowledgeable regarding HIV incidences and comorbidities in the older patient in today's day and age
• Become aware of the most common reasons for hospital admission as well as ICU admission in persons living with HIV
• Understand the management of the HIV patient who is hospitalized as well as the role of antiretroviral therapy during hospitalization

9:55-10:35 AM  2024 Update on Pulmonary Arterial Hypertension
Mary R. Suchyta, DO, FACOI
In this session you'll learn:

• FDA approved PAH drugs in light of the newest guidelines
• Drug category updates
• Future directions in the treatment of PAH

10:40-11:30 AM  An Evidence Based Medicine Update for Hospitalists  
Andrew Buelt, DO
In this session you'll learn:

• To implement updated evidence from recent articles into hospital based patient care
• To critically analyze scientific articles and journals applicable to hospital medicine
• Treatment modalities best suited for improvement in patient outcomes

11:35 AM - 12:35 PM  New Considerations in Heart Failure: New Roles for SLGT-2 Inhibitors
Andrew Buelt, DO
In this session you will:

• Evaluate the evidence supporting the use of SGLT2 inhibitors in the management of heart failure, including their impact on cardiovascular outcomes
• Discuss the limitations in the trials used for FDA approval of the SGLT2 inhibititor
• Understand the difference in benefit with SGLT2 inhibitors between systolic and diastolic dysfunction

12:40-1:35 PM  Sleep Update in the Management of Insomnia
Michelle Zetoony Nudell, DO, FACOI
In this session you'll learn:

• Updates in management of sleep in hospitalized patients
• To modify sleep components to improve patient outcomes in hospitalized settings
• About medications for sleep

1:40-2:15 PM  Approaching the Apnea Patient: Obstructive to Central  
Lisa Whims-Squires, DO, FACOI

2:20-3:05 PM  Updates in the Management of Acute and Chronic Hypertension with Review of CVA Risk
John R. Dahdah, DO
In this session you'll learn:

• To distinguish hypertensive crises from essential hypertension
• Management strategies for inpatient and outpatient hypertension management
• The pertinence of hypertension management to stroke risk reduction and management

3:10-3:35 PM  Use of Biosimilars in Inflammatory and Immunological Diseases
Brinda Joshi, DO
In this session you'll learn to:

• Define biosimilars in inflammatory diseases
• Describe issues of concern in the use of biosimilars in clinical practice
• Summarize team strategies for improving care coordination and communication to advance the use of biosimilars in treating patients with inflammatory diseases 

Friday, April 12

8:00 - 8:45 AM  2024 Hospital Coding Updates
Jill M. Young, CPC, CIMC, CEDC
In this session you'll learn:

• The differences for split shared visits in 2024
• Physician rules for supervision in 2024
• The new Hospital and Observation Services codes and guidelines

8:50 - 9:40 AM  Inpatient Goals of Care: Discussion Strategies for Transition to Palliative Care/Hospice
Annette T. Carron, DO, MACOI
In this session you'll learn:

• Scripting options to counsel patients/families facing serious illness
• What assistance is available to have difficult conversations
• Preemptive and management strategies for each conversation

9:45-10:35 AM  Transitions Between Inpatient and Outpatient Management of Patients with Chronic Pain
Jean Storm, DO, FACOI
In this session you'll learn:

• The key challenges and factors influencing the transition from inpatient to outpatient management in chronic pain patients
• Best practices for developing personalized care plans to facilitate seamless transitions and improve patient outcomes
• Challenges associated with transitions and solutions to overcome barriers for more effective chronic pain management

10:40-11:30 AM  Meeting Hospital Metric Goals
Ariana Peters, DO, FACOI
In this session you'll learn:

• The metrics commonly used in an acute care setting
• The importance of these metrics to a hospital provider, and how they can impact them
• The financial metrics important to the C-suite and hospital finance/revenue cycle teams

11:35 AM - 12:20 PM  Update in the Large Vessel Vasculidities: Diagnosis and Treatment in Giant Cell Arteritis and Polymyalgia Rheumatica
Linda S. Brecher, DO, FACOI
In this session you'll learn to:

• Identify the clinical signs and symptoms supporting the diagnosis of polymyalgia rheumatica and giant cell arteritis
• Recognize the potential morbidity associated with untreated giant cell arteritis
• Define the treatment options for polymyalgia rheumatica and giant cell arteritis including strengths and limitations of medication choices

12:25 - 12:40 PM  2024 Licensing & Certifying Board Update: OCC
J. Rico Blanco, AOBIM Executive Director
In this session you'll learn to:

• Understand and maintain the Osteopathic Continuous Certification (OCC) process
• Gather information necessary to encourage osteopathic board certification
• Understand AOBIM board initiatives and opportunities

12:45 PM Closing Comments
Rick A. Greco, DO, MACOI & Mia A. Taormina, DO, FACOI